Comparison Hospital Admission between COPD with Acute Exacerbation Patients Receiving Dexamethasone from Prehospital and Not Receiving Dexamethasone by EMS System, Chiangrai Prachanukroh Hospital
Keywords:
Exacerbation of COPD, Dexamethasone, Emergency Medical ServiceAbstract
The objective of this study was to compare of hospital admission between chronic obstructive pulmonary disease (COPD) with acute exacerbation patients that received dexamethasone and patients who did not receive dexamethasone from prehospital care by EMS system, Chiangrai Prachanukroh hospital. This research was conducted as an observational retrospective study. Data were obtained from the review of electronic medical records and EMS records of COPD with acute exacerbation (AE) patients who were transferred by EMS system to Chiangrai Prachanukroh hospital from 1st October 2019 to 31st December 2021. The result showed that 319 patients were included of whom 69 (21.63%) patients received prehospital dexamethasone and 250 (78.37%) patients did not receive the drug. Patients who received dexamethasone from prehospital care had hospital admission ratio of 1.13 (p=0.513). The mean difference in length of hospital stay was 1.52 days (p=0.478) and revisit within 48 hours ratio was 2.25 times (p=0.196) compared to patients who did not receive dexamethasone. In conclusion, prehospital dexamethasone did not reduce hospital admission length of hospital stay and revisit within 48 hours in COPD with AE patients.
References
สมาคมอุรเวชช์แห่งประเทศไทย ในพระบรมราชูปถัมภ์. ข้อแนะนำการดูแลรักษาผู้ป่วยโรคปอดอุดกั้นเรื้อรัง, 2560. กรุงเทพมหานคร: บียอนเอ็นเทอร์ไพรส์; 2560.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of chronic obstructive pulmonary disease (2020 Report). Deer Park , IL: Global Initiative for Chronic Obstructive Lung Disease; 2020.
อานนท์ วิทยานุกูลลักษณ์. ข้อมูลผู้ป่วยโรคปอดอุดกั้นเรื้อรัง (COPD) เขตสุขภาพที่ 1 [อินเทอร์เน็ต]. [สืบค้นเมื่อ 7 พ.ค. 2564]. แหล่งข้อมูล: https://www.chiangmaihealth.go.th/cmpho_web/document/200816159755596654.pdf
Sneath E, Bunting D, Hazell W, Tippett V, Yang IA. Pre-hospital and emergency department pathways of care for exacerbations of chronic obstructive pulmonary disease (COPD). Journal of Thoracic Disease 2019; 11(S17):S2221-9.
Hoogendoorn M, Hoogenveen RT, Rutten-van MP, Vestbo J, Feenstra TL. Case fatality of COPD exacerbations: A meta-analysis and statistical modelling approach. European Respiratory Journal. 2010;37(3):508–15.
Krishnan AM, Ramanathan R, Sama S, Manek G, Datta D, Alunilkummannil J. Impact of 30-day readmission on outcomes and resource utilization among patients with acute exacerbation of COPD. Chest 2019;156(4): 153-61.
Guerrero M, Crisafulli E, Liapikou A, Huerta A, Gabarrús A, Chetta A, et al. Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: A long-term observational study. PLOS ONE 2016;11(3):1-15.
Ringbaek TJ, Terkelsen J, Lange P. Outcomes of acute exacerbations in COPD in relation to pre-hospital oxygen therapy. European Clinical Respiratory Journal 2015; 2(1):1-6.
Hodroge S, Glenn M, Breyre A, Lee B, Aldridge N, Sporer K, et al. Adult patients with respiratory distress: Current evidence-based recommendations for Prehospital Care. Western Journal of Emergency Medicine. 2020;21(4):849-57.
García-Sanz MT, Pol-Balado C, Abellás C, Cánive-Gómez JC, Antón-Sanmartin D, González-Barcala FJ. Factors associated with hospital admission in patients reaching the Emergency Department with COPD exacerbation. Multidisciplinary Respiratory Medicine. 2012;7(1):6.
Piquet J, Chavaillon J-M, David P, Martin F, Blanchon F, Roche N. High-risk patients following hospitalisation for an acute exacerbation of COPD. European Respiratory Journal. 2013;42(4):946–55.
Menaik R. Appropriate selection of corticosteroids in treating asthma and COPD.JEMS journal of emergency medical services [Internet]. 2017 [cited 2022 Oct 2]. Available from: https://www.jems.com/patient-care/appropriate-selection-of-corticosteroids-in-treating-asthma-and-copd
Miyabo S, Nakamura T, Kuwazima S, Kishida S. A comparison of the bioavailability and potency of dexa-methasone phosphate and sulphate in man. Eur J Clin Pharmacol. 1981;20(4):277-82.
Walters JA, Tan DJ, White CJ, Gibson PG, Wood-Baker R, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014;1:(9):1-4
Peters GA, Cash RE, Goldberg SA, Ordoobadi AJ, Camargo CA Jr. Out-of-Hospital Presentation and Management of Asthma and Chronic Obstructive Pulmonary Disease Exacerbations in the United States: A Nationwide Retrospective Cohort Study. Ann Emerg Med 2023; 81(6):679-90.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Emergency Medical Services of Thailand
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
